Review article: new receptor targets for medical therapy in irritable bowel syndrome
about
Impact of psychological stress on irritable bowel syndromeChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsInterplay between mast cells, enterochromaffin cells, and sensory signaling in the aging human bowelStress and visceral pain: from animal models to clinical therapiesLubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndromeLX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotoninLow-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.Effect of the α2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults.Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study.Optimal management of constipation associated with irritable bowel syndromeHerbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.Current and emerging therapies for the management of functional gastrointestinal disorders.Drug development for the irritable bowel syndrome: current challenges and future perspectivesNociceptor sensitization in pain pathogenesisThe brain-gut axis in abdominal pain syndromes.Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome.Linaclotide.ZD 7288, an HCN channel blocker, attenuates chronic visceral pain in irritable bowel syndrome-like rats.Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.Behavioural and new pharmacological treatments for constipation: getting the balance rightPharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.Rifaximin for the treatment of irritable bowel syndrome.New treatments for IBS.Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions.Medical Therapies in the Pipeline for Irritable Bowel Syndrome.The gut as a sensory organ.Combined effect of early life stress and acute stress on colonic sensory and motor responses through serotonin pathways: differences between proximal and distal colon in rats.
P2860
Q26853213-BD4E984F-5B84-4469-A1F9-15CAAA144BB1Q28079705-CFFA791E-5DEE-4FA5-8244-497F593E2A17Q28822420-2C03F571-3EBB-4F70-99C7-9AB7A291299DQ30459512-B725F66E-DDFC-416E-92C1-3C1F8A3BD7C1Q34345704-0AB2882B-3703-4C4C-BE38-3A2973DE8F73Q34790812-030CDC18-4C8F-47C4-85D8-E9A8ABB06D42Q34992347-3E36AD21-3839-479D-B102-7C3F287811AFQ35159654-F41406C3-F40E-4B56-BF72-662F1F1A7E2AQ35161361-64F4AC40-98F8-421B-88DE-D8E4ECE2AD0EQ35586543-65C5CCEC-DA6B-41A2-91CD-B4F64C26A5DBQ36123979-53A4BF9B-2F12-449A-A31F-CC13712A0ACBQ36443725-8C583BB8-F45A-412D-BB5B-E3EBABD8A775Q36579818-B023EE50-5740-47C3-9334-E8EA87BFC4A6Q37254618-50C5C229-C55D-4E42-A566-58BD12CB026AQ37280260-E9FE8D20-4BC0-442B-9D4D-CBBC216BA833Q37322657-A51433E9-D1C1-4FC8-9E3F-D97B3966D52DQ37340041-25BA88ED-1649-4A90-91B1-6AECB4FE2CB9Q37602749-84457FE0-B3C4-4402-B2DB-5976DB386BA3Q37624734-FD79C1A3-6376-44D5-8927-91DD2624BBF5Q37783838-69A2C093-A67B-4155-A6D8-120F30ADBE17Q37954521-E152501C-7444-4F11-9296-F7C926BADE01Q37976477-EE074A4E-7137-45D6-B780-A0600083CDE2Q38059436-EF6B6BD3-9089-4774-9A97-D3F43A8B1236Q38121999-378A6872-FEC9-43D6-A3CC-EA6EB126C2AAQ38175457-680C34C0-ED5E-4291-A2F2-08E895D841D3Q41904421-5B97C0BA-E08F-4590-8286-6D1C02C998FAQ42374437-372B0D6C-8034-4D23-8D41-CC7BD856A72CQ45894561-62302277-2A07-441E-A043-29F22786324BQ46660474-0393DF4F-EE54-498F-91D8-D43C0B4F0C2B
P2860
Review article: new receptor targets for medical therapy in irritable bowel syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Review article: new receptor targets for medical therapy in irritable bowel syndrome
@ast
Review article: new receptor targets for medical therapy in irritable bowel syndrome
@en
type
label
Review article: new receptor targets for medical therapy in irritable bowel syndrome
@ast
Review article: new receptor targets for medical therapy in irritable bowel syndrome
@en
prefLabel
Review article: new receptor targets for medical therapy in irritable bowel syndrome
@ast
Review article: new receptor targets for medical therapy in irritable bowel syndrome
@en
P2860
P1476
Review article: new receptor targets for medical therapy in irritable bowel syndrome
@en
P2093
M Camilleri
P2860
P356
10.1111/J.1365-2036.2009.04153.X
P407
P577
2010-01-01T00:00:00Z